YMAGUS Trademark
Trademark Overview
On Wednesday, November 29, 2017, a trademark application was filed for YMAGUS with the United States Patent and Trademark Office. The USPTO has given the YMAGUS trademark a serial number of 79223669. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, November 22, 2024. This trademark is owned by Novartis AG. The YMAGUS trademark is filed in the Pharmaceutical Products category with the following description:
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the pre...
General Information
| Serial Number | 79223669 |
| Word Mark | YMAGUS |
| Filing Date | Wednesday, November 29, 2017 |
| Status | 709 - CANCELLED - SECTION 71 |
| Status Date | Friday, November 22, 2024 |
| Registration Number | 5461556 |
| Registration Date | Tuesday, May 8, 2018 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 20, 2018 |
Trademark Statements
| Goods and Services | Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, November 22, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Novartis AG |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 25 - NOT AVAILABLE |
| Address | CH |
| Party Name | Novartis AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 25 - NOT AVAILABLE |
| Address | CH |
| Party Name | Novartis AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 25 - NOT AVAILABLE |
| Address | CH |
Trademark Events
| Event Date | Event Description |
| Thursday, December 21, 2017 | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB |
| Friday, December 22, 2017 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Tuesday, December 26, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, December 30, 2017 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, January 3, 2018 | ASSIGNED TO EXAMINER |
| Friday, January 5, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, January 31, 2018 | NOTICE OF PUBLICATION |
| Tuesday, February 20, 2018 | PUBLISHED FOR OPPOSITION |
| Tuesday, May 8, 2018 | REGISTERED-PRINCIPAL REGISTER |
| Thursday, June 7, 2018 | GRANT OF PROTECTION CREATED, TO BE SENT TO IB |
| Friday, June 15, 2018 | FINAL DISPOSITION PROCESSED |
| Friday, June 15, 2018 | FINAL DISPOSITION NOTICE SENT TO IB |
| Friday, August 17, 2018 | NOTIFICATION PROCESSED BY IB |
| Friday, November 22, 2024 | CANCELLED SECTION 71 |
